Market Snapshot

BSE Sensex: 77550.25 1.20%
BSE 500: 35004.96 1.40%
BSE 200: 11020.66 1.36%
BSE 100: 25321.37 1.26%
BSE BANKEX: 62984.89 2.06%
BSE IT: 29902.28 -1.70%
Nifty 50: 24050.6 1.16%
Nifty 500: 22346.75 1.40%
Nifty 200: 13581.3 1.36%
Nifty 100: 24809.8 1.32%
Nifty Midcap 100: 57843.95 1.52%
Nifty Small 100: 16840.1 1.65%
Nifty IT: 31030.6 -1.91%
Nifty PSU Bank: 8778.25 2.01%

News:

Siyaram Recycling Industries g...
SJVN ends higher after appoint...
IT stocks slide after TCS? Q4 ...
Kesoram Industries Ltd leads l...
IFB Industries gains on appoin...

Sun Pharma Advanced Research Company Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

10 Apr 2026 | 03:59 PM

148.15

2.15 (1.47%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

2.85%

Return (1Y)

Underperformed BSE Healthcare by 4.35%
More Volatile

3.23%

Standard Deviation (1Y)

Higher than BSE Healthcare by 2.39%
Inconsistent Performer

3/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

204

108

News & Announcements

Sun Pharma Advanced Research Company announces change in senior management
7 days ago

Sun Pharma Advanced Research Company announces change in senior management

03 - Apr - 2026 12:00 | 7 days ago

Sun Pharma Advanced Research Company announced that Dr. Shravanti Bhowmik, Head of Operations Management, and a member of Senior Management Team of the Company has resigned from her position in the Company with effect from the close of business hours on 31 March 2026.
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 80.42 crore in the December 2025 quarter
60 days ago

Sun Pharma Advanced Research Company reports consolidated net loss of Rs 80.42 crore in the December 2025 quarter

09 - Feb - 2026 12:00 | 60 days ago

Net Loss of Sun Pharma Advanced Research Company reported to Rs 80.42 crore in the quarter ended December 2025 as against net loss of Rs 79.51 crore during the previous quarter ended December 2024. Sales declined 43.33% to Rs 8.45 crore in the quarter ended December 2025 as against Rs 14.91 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 8.45 14.91 -43

OPM % -670.30 -494.23 -

PBDT -65.42 -76.30 14

PBT -67.99 -79.44 14

NP -80.42 -79.51 -1

Powered by Capital Market - Live News
Sun Pharma Advanced Research Company announces board meeting date
65 days ago

Sun Pharma Advanced Research Company announces board meeting date

04 - Feb - 2026 12:00 | 65 days ago

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on 9 February 2026.
Powered by Capital Market - Live News
Sun Pharma Advanced Research Company to convene EGM
83 days ago

Sun Pharma Advanced Research Company to convene EGM

17 - Jan - 2026 12:00 | 83 days ago

Sun Pharma Advanced Research Company announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 9 February 2026.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Sun Pharma Advanced Research Company Ltd has increased by 15.92% since past 3 Months
MF shareholding in Sun Pharma Advanced Research Company Ltd has decreased by -25.03% since past 3 Months
FII shareholding in Sun Pharma Advanced Research Company Ltd has decreased by -8.48% since past 1 Year
MF shareholding in Sun Pharma Advanced Research Company Ltd has increased by 50.25% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	8.45	14.91	-43
OPM %	-670.30	-494.23	-
PBDT	-65.42	-76.30	14
PBT	-67.99	-79.44	14
NP	-80.42	-79.51	-1

General Notifications

My Notifications

Research Notifications

Sun Pharma Advanced Research Company Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

148.15 2.15 (1.47%)

News & Announcements

Price vs Volume

Stock Trivia

Sun Pharma Advanced Research Company Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

148.15

2.15 (1.47%)